XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,139,000 | -37.9% | 465,049 | +3.2% | 0.02% | -35.3% |
Q2 2021 | $1,833,000 | -6.3% | 450,414 | +3.9% | 0.03% | -17.1% |
Q1 2021 | $1,956,000 | +27.2% | 433,710 | +38.7% | 0.04% | +17.1% |
Q4 2020 | $1,538,000 | -25.1% | 312,590 | -9.8% | 0.04% | -50.0% |
Q3 2020 | $2,054,000 | +127.0% | 346,428 | +1.8% | 0.07% | +112.1% |
Q2 2020 | $905,000 | -35.5% | 340,403 | +312.6% | 0.03% | -66.7% |
Q4 2018 | $1,403,000 | -39.2% | 82,504 | -37.1% | 0.10% | -20.8% |
Q3 2018 | $2,306,000 | -7.1% | 131,145 | +0.3% | 0.12% | -16.1% |
Q2 2018 | $2,481,000 | – | 130,700 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|